Twitter

Archive for October 21st, 2011


Yellow Creek Elementary recognizes Breast Cancer Awareness month

… Brylee Ellison was escorted in by two gentlemen from LMU. She was diagnosed with Leukemia at a very young age. She has now been off chemotherapy for a year. …

Read More...

The trouble with my blood

… to be at the centre of a cancer cluster: one friend was dying of leukaemia in Hammersmith hospital, another was in the process of being diagnosed, a third had …

Read More...

Kumba Iron Ore pumps millions into bone marrow initiative

… establish the interventions required. The SABMR aims to improve the chances of patients with leukaemia and other life-threatening blood disorders by finding matching donors for bone marrow stem cell …

Read More...

Despite bear bash, AEZS and KERX appear to have odds for FDA approval on their side

… Company $8 million for exclusive rights on Perifosine. Its pro-apoptotic action in acute myelogenous leukemia cells sensitizes these cells to chemotherapy 9 and its JNK-dependent pro-apoptotic action in T-acute …

Read More...

Coach misses his team during battle with leukemia

… and his family realized their worst fears when Smith was diagnosed with Acute Myloid Leukemia, cancer of the blood. The 35-year-old had to put everything else on hold as …

Read More...

Marrow plea

… Paphos this Sunday in the search to find a suitable donor for a young leukaemia patient. Sixteen year-old Kathryn Hadjipetrou, or Kat as she is known to family and …

Read More...

Longmont’s Current battles leukemia, inspires community

… 20111007_VROL_CURRENT.JPG Longmont senior Olivia Current is battling an aggressive form of leukemia and as a result has had to sit out the volleyball season. In November …

Read More...

Nilotinib and LDE225 in the Treatment of Phase Chronic Myeloid Leukemia Patients Who Developed Resistance to Prior Therapy

Condition :   Philadelphia Chromosome Positive Chronic Myelogenous Leukemia Intervention :   Drug: Imatinib + LDE225 Sponsor :   Novartis Pharmaceuticals Not yet recruiting – verified October 2011

Read More...

Dasatinib and Cyclosporine in Patients With Chronic Myelogenous Leukemia (CML)

Condition :   Chronic Myelogenous Leukemia Intervention :   Drug: Dasatinib and Cyclosporine Sponsors :   University of Colorado, Denver;   National Cancer Institute and Leukemia and Lymphoma Society Recruiting – verified October 2011

Read More...

A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma

Condition :   Multiple Myeloma Intervention :   Drug: LGH447 Sponsor :   Novartis Pharmaceuticals Not yet recruiting – verified October 2011

Read More...